HARRY J LEONHARDT

CIK 1286102 · GC & Chief Compliance Officer · last filed 2025-01-08

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

4

Total Filings

34

Lifetime Open-Market Net

-$356.7K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Poseida Therapeutics, Inc. (PSTX) Delisted GC & Chief Compliance Officer 0 $9.50 $0 $0 5 2025-01-08
HALOZYME THERAPEUTICS, INC. (HTI) Delisted SVP, GC 66,373 $0 15 2019-04-15
AMYLIN PHARMACEUTICALS INC (AMLN) Delisted SVP, Legal, Compliance and Cor 39,431 -$58.2K 5 2012-03-07
SENOMYX INC (SNMX) Delisted SVP, Gen.Counsel & Corp. Sec. 48,937 -$298.6K 8 2007-09-04

Recent Filings · Page 4 of 4

34 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2007-04-17 SENOMYX INC (SNMX) Delisted Sell (S) −4,752 -$62.2K EDGAR
2007-03-01 SENOMYX INC (SNMX) Delisted Grant (A) $0 EDGAR
2007-02-16 SENOMYX INC (SNMX) Delisted Sell (S) −1,500 -$19.1K EDGAR
2007-01-17 SENOMYX INC (SNMX) Delisted Sell (S) −1,500 -$19.2K EDGAR
Showing 3134 of 34
Page 4 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.